Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

NCT07461220 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

PARKINSON DISEASE (Disorder)
Apathy
Safety

Interventions

DRUG: IRL757
DRUG: Placebo

Sponsor

Integrative Research Laboratories AB

Collaborators

[object Object]